The effect of L-5-hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro-4-4602) in depressive patients
Matussek, N.; Angst, J.; Benkert, O.; Gmür, M.; Papousek, M.; Rüther, E.; Woggon, B.
Advances in Biochemical Psychopharmacology 11: 399-404
1974
ISSN/ISBN: 0065-2229 PMID: 4602669 Document Number: 76865
Document emailed within 1 workday
Related Documents
Matussek, N.; Benkert, O.; Schneider, K.; Otten, H.; Pohlmeier, H. 1970: Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions Arzneimittel-Forschung 20(7): 934-935Geissbuhler, F.; Eisenring, J.J.; Friedli, P.; Bartholini, G.; Tissot, R. 1972: Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects L'Encephale 61(2): 127-148
Stammler, A.; Vielhaber, K. 1972: Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 40(10): 564-568
Fischer, P.A.; Schneider, E.; Jacobi, P.; Maxion, H. 1973: Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor Die Medizinische Welt 24(45): 1742-1746
Rabadeau Dumas, J.L.; Rondot, P.; Cardon, P. 1977: Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor Therapie 32(2): 161-172
Popova, G.N.; Berezov, T.T.; Burobina, S.S. 1973: 5-hydroxytryptophan decarboxylase activity in benign tumors in man Voprosy Meditsinskoi Khimii 19(1): 99-102
Marmaras, V.J.; Fragoulis, E.G. 1970: 5-Hydroxytryptophan-decarboxylase activity in the decapod crustacean Upogebia littoralis Experientia 26(4): 359-360
Benkert, O.; Lücke, K.H. 1976: The effect of thyrotrophin releasing hormone versus placebo in combination with basic imipramine therapy of depressive patients Arzneimittel-Forschung 26(6): 1162-1164
Fuller, R.W.; Perry, K.W. 1983: Decreased accumulation of brain 5-hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p-chloroamphetamine Journal of Pharmacy and Pharmacology 35(9): 597-598
Eisenlohr, J.J.; Gehlen, W. 1974: Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) Münchener Medizinische Wochenschrift 116(28): 1353-1356
Slotkin, T.A.; Seidler, F.J.; Trepanier, P.A.; Whitmore, W.L.; Lerea, L.; Barnes, G.A.; Weigel, S.J.; Bartolome, J. 1982: Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase Journal of Pharmacology and Experimental Therapeutics 222(3): 741-745
Hui, K.S. 1976: The effect of thiazol-4-yimethoxyamine, a histidine decarboxylase inhibitor, on the development of morphine tolerance and physical dependance in mice Experientia 32(10): 1313-1315
Prakash, N.J.; Schechter, P.J.; Grove, J.; Koch-Weser, J. 1978: Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice Cancer Research 38(9): 3059-3062
Okada, S.; Ishii, K.; Tanokuchi, S.; Hamada, H.; Ichiki, K.; Ota, Z. 1995: Effect of alpha-glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus Journal of International Medical Research 23(6): 492-496
Pontiroli, A.E.; Castegnaro, E.; Vettaro, M.P.; Viberti, G.C.; Pozza, G. 1977: Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine Acta Endocrinologica 84(1): 36-44
Fuller, R.W.; Snoddy, H.D.; Molloy, B.B. 1975: Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake Research Communications in Chemical Pathology and Pharmacology 10(1): 193-196
Khomutov, R.M.; Zavalova, L.L.; Syrku, V.I.; Artamonova, E.I.; Khomutov, A.R. 1983: An effective inhibitor of S-adenosylmethionine decarboxylase Bioorganicheskaia Khimiia 9(1): 130-133
Di Pasquale, P.; Paterna, S. 1999: The effect of a combination ACE inhibitor and beta-blockers in acute myocardial infarct Giornale Italiano di Cardiologia 29(8): 938-942
Sills, T.; Heptinstall, S. 1986: Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour Thrombosis and Haemostasis 55(3): 305-308
Chen, J.; Bhansali, S.; Neelakantham, S.; Trusley, C.; Majumdar, T.; Rebello, S.; Sunkara, G.; Meyers, C. 2015: Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects International Journal of Clinical Pharmacology and Therapeutics 53(4): 317-324